Lyra Therapeutics, Inc. (LYRA)
NASDAQ: LYRA · Real-Time Price · USD
0.172
-0.003 (-1.49%)
Dec 24, 2024, 4:00 PM EST - Market closed
Lyra Therapeutics Market Cap
Lyra Therapeutics has a market cap or net worth of $11.28 million as of December 24, 2024. Its market cap has decreased by -94.60% in one year.
Market Cap
11.28M
Enterprise Value
-5.02M
1-Year Change
-94.60%
Ranking
Category
Stock Price
$0.17
Market Cap Chart
Since May 1, 2020, Lyra Therapeutics's market cap has decreased from $230.14M to $11.28M, a decrease of -95.10%. That is a compound annual growth rate of -47.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 24, 2024 | 11.28M | -95.91% |
| Dec 29, 2023 | 275.43M | 175.60% |
| Dec 30, 2022 | 99.94M | 76.26% |
| Dec 31, 2021 | 56.70M | -61.52% |
| Dec 31, 2020 | 147.37M | -35.97% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AIM ImmunoTech | 11.97M |
| Brainstorm Cell Therapeutics | 11.81M |
| Jaguar Health | 11.52M |
| Imunon | 11.47M |
| Relmada Therapeutics | 11.45M |
| Immuron | 11.43M |
| Cellectar Biosciences | 11.38M |
| Sensei Biotherapeutics | 11.37M |